Búsqueda | BVS CLAP/SMR-OPS/OMS

1.

Guidelines for the management of inflammatory bowel disease in adults.

Mowat, Craig; Cole, Andrew; Windsor, Al; Ahmad, Tariq; Arnott, Ian; Driscoll, Richard; Mitton, Sally; Orchard, Tim; Rutter, Matt; Younge, Lisa; Lees, Charlie; Ho, Gwo-Tzer; Satsangi, Jack; Bloom, Stuart.

Gut ; 60(5): 571-607, 2011 May.

Artículo en Inglés | MEDLINE | ID: mdl-21464096

2.

Influence of comorbidities on treatment considerations for first-line biologic prescribing in patients with inflammatory bowel disease in the UK.

Akbar, Ayesha; Orchard, Tim; Powell, Nick; Selinger, Christian; Tibbatts, Clare.

Frontline Gastroenterol ; 13(6): 490-496, 2022.

Artículo en Inglés | MEDLINE | ID: mdl-36250175

3.

GPs have central role in managing IBD.

Orchard, Tim.

Practitioner ; 252(1711): 14, 17-8, 20-1, 2008 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-18972795

4.

Combination therapy for systemic sclerosis-associated pneumatosis intestinalis.

Koysombat, Kanyada; Capanna, Maria Vittoria; Stafford, Nina; Orchard, Tim.

BMJ Case Rep ; 20182018 Jul 11.

Artículo en Inglés | MEDLINE | ID: mdl-30002210

5.

Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

Heap, Graham A; So, Kenji; Weedon, Mike; Edney, Naomi; Bewshea, Claire; Singh, Abhey; Annese, Vito; Beckly, John; Buurman, Dorien; Chaudhary, Rakesh; Cole, Andrew T; Cooper, Sheldon C; Creed, Tom; Cummings, Fraser; de Boer, Nanne K; D'Inca, Renata; D'Souza, Richard; Daneshmend, Tawfique K; Delaney, Michael; Dhar, Anjan; Direkze, Natalie; Dunckley, Paul; Gaya, Daniel R; Gearry, Richard; Gore, Steve; Halfvarson, Jonas; Hart, Ailsa; Hawkey, Chris J; Hoentjen, Frank; Iqbal, Tariq; Irving, Peter; Lal, Simon; Lawrance, Ian; Lees, Charlie W; Lockett, Melanie; Mann, Stephen; Mansfield, John; Mowat, Craig; Mulgrew, Chris J; Muller, Frank; Murray, Charles; Oram, Richard; Orchard, Tim; Parkes, Miles; Phillips, Rosemary; Pollok, Richard; Radford-Smith, Graham; Sebastian, Shaji; Sen, Sandip; Shirazi, Tarek.

J Crohns Colitis ; 10(2): 149-58, 2016 02.

Artículo en Inglés | MEDLINE | ID: mdl-26619893

6.

Enteropathic arthritis.

Holden, Wendy; Orchard, Tim; Wordsworth, Paul.

Rheum Dis Clin North Am ; 29(3): 513-30, viii, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-12951865

7.

UK guidance opens new therapeutic avenues for patients with moderate-severe ulcerative colitis.

Orchard, Tim.

Expert Rev Gastroenterol Hepatol ; 10(3): 281-2, 2016.

Artículo en Inglés | MEDLINE | ID: mdl-26651595

8.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Harbord, Marcus; Annese, Vito; Vavricka, Stephan R; Allez, Matthieu; Barreiro-de Acosta, Manuel; Boberg, Kirsten Muri; Burisch, Johan; De Vos, Martine; De Vries, Anne-Marie; Dick, Andrew D; Juillerat, Pascal; Karlsen, Tom H; Koutroubakis, Ioannis; Lakatos, Peter L; Orchard, Tim; Papay, Pavol; Raine, Tim; Reinshagen, Max; Thaci, Diamant; Tilg, Herbert; Carbonnel, Franck.

J Crohns Colitis ; 10(3): 239-54, 2016 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-26614685

9.

NICE guidance for anti-tumour necrosis factor therapy in Crohn's disease: what does it mean for the inflammatory bowel disease community?

Orchard, Tim.

Frontline Gastroenterol ; 1(3): 144-146, 2010 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-28839566

10.

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.

Van Assche, Gert; Dignass, Axel; Panes, Julian; Beaugerie, Laurent; Karagiannis, John; Allez, Mathieu; Ochsenkühn, Thomas; Orchard, Tim; Rogler, Gerhard; Louis, Edouard; Kupcinskas, Limas; Mantzaris, Gerassimos; Travis, Simon; Stange, Eduard.

J Crohns Colitis ; 4(1): 7-27, 2010 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-21122488

11.

Extraintestinal complications of inflammatory bowel disease.

Orchard, Tim.

Curr Gastroenterol Rep ; 5(6): 512-7, 2003 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-14602062

12.

Do extraintestinal manifestations predict disease course, severity, and/or activity in IBD?

Walker, David; Orchard, Tim.

Inflamm Bowel Dis ; 14 Suppl 2: S200-1, 2008 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-18816647

13.

High-risk features confer an increased risk of significant GI pathology in patients aged less than 50 years with dyspepsia.

Powell, Nick; Mawdsley, Joel; Hoare, Jonathan; Negus, Rupert; Thomas, Huw; Teare, Julian; Orchard, Tim.

Gastrointest Endosc ; 67(6): 1007, 2008 May.

Artículo en Inglés | MEDLINE | ID: mdl-18440390

BVS CLAP/SMR-OPS/OMS

Centro Latinoamericano de Perinatología, Salud de la Mujer y Reproductiva

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Guidelines for the management of inflammatory bowel disease in adults.

Influence of comorbidities on treatment considerations for first-line biologic prescribing in patients with inflammatory bowel disease in the UK.

GPs have central role in managing IBD.

Combination therapy for systemic sclerosis-associated pneumatosis intestinalis.

Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

Enteropathic arthritis.

UK guidance opens new therapeutic avenues for patients with moderate-severe ulcerative colitis.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.

NICE guidance for anti-tumour necrosis factor therapy in Crohn's disease: what does it mean for the inflammatory bowel disease community?

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.

Extraintestinal complications of inflammatory bowel disease.

Do extraintestinal manifestations predict disease course, severity, and/or activity in IBD?

High-risk features confer an increased risk of significant GI pathology in patients aged less than 50 years with dyspepsia.